CRISPR-Cas9 removed an extra chromosome 21 from some Down syndrome cells in the lab. Learn what the 30.6% result means and ...

CRISPR Therapeutics (Nasdaq: CRSP) today announced that clinical data from the Phase 1b trial of CTX310 ®, its ...

Most of any gains (or lack thereof) from here will be driven by just three factors.

Gene-editing techniques could soon allow researchers to replace entire genes and engineer complex cellular circuits — if the ...

Nabsys 2.0, LLC ("Nabsys"), a pioneer in Electronic Genome Mapping (EGM), today announced the publication of a new preprint demonstrating that CRISPR/Cas9 can be used to customize how EGM identifies ...

Japanese researchers used CRISPR-Cas9 to remove the extra chromosome 21 from cells in a lab. It’s a real breakthrough — but ...

A new engineered gene-editing system, proven in bacteria and showing promise for use in plants, animals and humans, addresses ...

CRISPR halves model-generation time and cuts costs by ~40%, while automation, aquatic models, genetic testing and cryobanking boost efficiency and client retention.Dublin, Oct. 07, 2026 (GLOBE ...

Anthropic’s claim its AI agents discovered an unusual pattern in viral DNA similar to what’s seen in the gene-editing tool ...

The pioneers of the CRISPR gene-editing tool won a Nobel prize in 2020, and for good reason. The breakthrough has revolutionised biology, and is also transforming medicine and farming. Now, AI company ...

Anthropic's Claude AI has just discovered a previously unknown enzyme system that bears a striking resemblance to the ...

CRISPR Therapeutics AG remains a long-term Buy, anchored by Casgevy's success and management’s execution in ex vivo gene editing. Click for more on CRSP.